Next, we analyzed the anti-apoptotic effects of dabrafenib, because vemurafenib, a selective inhibitor of B-Raf containing the melanoma-causing V600E pathogenic mutation (BRAFV600E), was reported to suppress apoptosis in non-BRAFV600E-mutated cells (37). Here, BRAF is linked to melanoma.